Stryker announces 2023 sales surpassed $20 billion
09 January 2024 - 12:00AM
Stryker (NYSE:SYK) announced today that it surpassed $20 billion in
annual sales for the first time in its history during the month of
December, 2023.
“We are excited to surpass this major milestone and to share
with our employees as we have our kick-off meetings for 2024,” said
Kevin Lobo, Chair and Chief Executive Officer. “This means that we
are positively impacting more customers and patients than
ever.”
Stryker will disclose additional information regarding its 2023
financial results during its Q4 and Full Year Earnings Call,
scheduled for January 30, 2024.
About Stryker
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in MedSurg, Neurotechnology, Orthopaedics and Spine that
help improve patient and healthcare outcomes. Alongside its
customers around the world, Stryker impacts more than 130 million
patients annually. More information is available at
www.stryker.com.
Contacts
For investor inquiries please contact:Jason
Beach, Vice President, Investor Relations at 269-385-2600 or
jason.beach@stryker.com
For media inquiries please contact:Yin Becker,
Vice President, Chief Corporate Affairs Officer at 269-385-2600 or
yin.becker@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Apr 2023 to Apr 2024